Patents by Inventor JUSTIN ERIC DELONG

JUSTIN ERIC DELONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • plant named ‘V1’
    Patent number: 11297789
    Abstract: The unique annual herbaceous Cannabis plant variety C. sativa ‘V1’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: April 12, 2022
    Assignee: GenCann, LLC
    Inventors: Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong
  • Cannabis plant named ‘V2’
    Patent number: 11297790
    Abstract: The unique annual herbaceous cannabis plant variety C. sativa ‘V2’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: April 12, 2022
    Assignee: GenCann, LLC
    Inventors: Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong
  • Cannabis plant named ‘V3’
    Patent number: 11297791
    Abstract: The unique annual herbaceous cannabis plant variety C. sativa ‘V3’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.
    Type: Grant
    Filed: April 10, 2020
    Date of Patent: April 12, 2022
    Assignee: GenCann, LLC
    Inventors: Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong
  • CANNABIS PLANT NAMED 'V1'
    Publication number: 20200323162
    Abstract: The unique annual herbaceous Cannabis plant variety C. sativa ‘V1’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.
    Type: Application
    Filed: April 10, 2020
    Publication date: October 15, 2020
    Inventors: MIKAH KAHN, BRENT KAISER, BLAKE BORGES, MICHAEL NAZARIAN, JUSTIN ERIC DELONG
  • CANNABIS PLANT NAMED 'V3'
    Publication number: 20200323164
    Abstract: The unique annual herbaceous cannabis plant variety C. sativa ‘V3’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.
    Type: Application
    Filed: April 10, 2020
    Publication date: October 15, 2020
    Inventors: MIKAH KAHN, BRENT KAISER, BLAKE BORGES, MICHAEL NAZARIAN, JUSTIN ERIC DELONG
  • CANNABIS PLANT NAMED 'V2'
    Publication number: 20200323163
    Abstract: The unique annual herbaceous cannabis plant variety C. sativa ‘V2’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.
    Type: Application
    Filed: April 10, 2020
    Publication date: October 15, 2020
    Inventors: MIKAH KAHN, BRENT KAISER, BLAKE BORGES, MICHAEL NAZARIAN, JUSTIN ERIC DELONG
  • Cannabis plant named 'V2'
    Publication number: 20200329600
    Abstract: The new cannabis plant variety ‘V2’ is provided. ‘V2’ is intended for use as medicinal herb for sale in cannabis dispensaries for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin and production of the unique terpene, farnesene.
    Type: Application
    Filed: August 5, 2019
    Publication date: October 15, 2020
    Inventors: Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, JUSTIN ERIC DELONG
  • Cannabis plant named 'V3'
    Publication number: 20200329601
    Abstract: The new cannabis plant variety C. sativa ‘V3’ is provided. ‘V3’ is intended for use as medicinal herb for sale in cannabis dispensaries and for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding feature of increased production of tetrahydrocannabivarin (THCV).
    Type: Application
    Filed: August 5, 2019
    Publication date: October 15, 2020
    Inventors: Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong
  • Cannabis plant named 'V1'
    Publication number: 20200329599
    Abstract: The new Cannabis plant variety ‘V1’ is provided. ‘V1’ is intended for use as medicinal herb for sale in Cannabis dispensaries and for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin (THCV) to a greater amount by percent weight than tetrahydrocannabinol (THC) and production of the unique terpene, farnesene.
    Type: Application
    Filed: August 5, 2019
    Publication date: October 15, 2020
    Inventors: Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong
  • plant named ‘V3’
    Patent number: PP33210
    Abstract: The new Cannabis plant variety C. sativa ‘V3’ is provided. ‘V3’ is intended for use as medicinal herb for sale in Cannabis dispensaries and for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding feature of increased production of tetrahydrocannabivarin (THCV).
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: June 29, 2021
    Assignee: GenCann, LLC
    Inventors: Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong
  • plant named ‘V2’
    Patent number: PP33211
    Abstract: The new Cannabis plant variety ‘V2’ is provided. ‘V2’ is intended for use as medicinal herb for sale in Cannabis dispensaries for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding feature of increased production of tetrahydrocannabivarin.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: June 29, 2021
    Assignee: GenCann, LLC
    Inventors: Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong
  • plant named ‘V1’
    Patent number: PP33212
    Abstract: The new Cannabis plant variety ‘V1’ is provided. ‘V1’ is intended for use as medicinal herb for sale in Cannabis dispensaries and for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin (THCV) to a greater amount by percent weight than tetrahydrocannabinol (THC).
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: June 29, 2021
    Assignee: GenCann, LLC
    Inventors: Mikah Kahn, Brent Kaiser, Blake Borges, Michael Nazarian, Justin Eric Delong